BioLineRx Encouraging Data from Pilot Phase of Phase 2 Combo Trial in First-Line Pancreatic Cancer

 6 of 11 Patients in the Pilot Phase Experienced a Partial Response, with 4 Confirmed; One Patient Experienced Resolution of the Hepatic Metastatic Lesion -

- Data Presented at AACR Special Conference on Pancreatic Cancer -

- Multi-Center, Randomized Phase 2 Study Currently Enrolling -

https://www.prnewswire.com/news-releases/biolinerx-announces-encouraging-data-from-pilot-phase-of-phase-2-combination-clinical-trial-with-motixafortide-in-first-line-pancreatic-cancer-pdac-301941126.html